Jaebok Choi

13PUBLICATIONS
24CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 13, 2025
BI-5756 Reduces Graft-Versus-Host Disease Through CB1-Mediated Treg Upregulation.

Sena Kim, Abdul-Jalil Dania, Sora Lim

|Nov 22, 2024
Itacitinib for prevention of graft-versus-host disease and cytokine release syndrome in haploidentical transplantation.

Ramzi Abboud, Mark A Schroeder, Michael P Rettig

|Apr 27, 2024
Novel JAK Inhibitors to Reduce Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation in a Preclinical Mouse Model.

Sena Kim, Peter Ruminski, Megh Singh

|Sep 09, 2023
S100A8 and S100A9 in Hematologic Malignancies: From Development to Therapy.

Farnaz Razmkhah, Sena Kim, Sora Lim

|Mar 21, 2023
The adrenal stress response is an essential host response against therapy-induced lethal immune activation.

Ling Guo, Weinan Wang, Qian Wang

|Dec 29, 2022
Restoring NK cell functions in AML relapse.

Sena Kim, Jaebok Choi

Pageof 3

Frequent Collaborators

7 joint publications

Sena Kim

3 joint publications

Sora Lim

2 joint publications

Bader Alahmari

2 joint publications

John F DiPersio